仟源医药
(300254)
| 流通市值：29.57亿 | | | 总市值：33.52亿 |
| 流通股本：2.26亿 | | | 总股本：2.56亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 173,800,715.3 | 870,786,344.11 | 611,473,385.33 | 372,995,932.54 |
| 营业收入 | 173,800,715.3 | 870,786,344.11 | 611,473,385.33 | 372,995,932.54 |
| 二、营业总成本 | 170,452,586.99 | 784,341,269.05 | 552,167,468.27 | 353,806,273.79 |
| 营业成本 | 57,396,288.28 | 284,037,044.8 | 197,366,071.05 | 116,232,891.81 |
| 税金及附加 | 2,069,683.97 | 11,875,494.55 | 7,952,681.02 | 4,802,773.9 |
| 销售费用 | 59,557,515.75 | 272,592,555.02 | 194,954,237.54 | 129,873,094.8 |
| 管理费用 | 33,411,863.32 | 143,526,100.78 | 97,207,255.2 | 63,346,121.01 |
| 研发费用 | 12,738,978.05 | 50,797,571.33 | 37,164,425.08 | 27,725,300.37 |
| 财务费用 | 5,278,257.62 | 21,512,502.57 | 17,522,798.38 | 11,826,091.9 |
| 其中:利息费用 | 5,337,217.37 | 21,631,274.12 | 17,626,899.56 | 11,923,412.63 |
| 其中:利息收入 | 90,042.54 | 245,508.66 | 206,977.16 | 177,263.12 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | -18,934,476 | - | - |
| 加:投资收益 | 859,682.15 | 3,971,475.89 | 1,469,358.04 | 113,156.56 |
| 资产处置收益 | - | 8,941,963.33 | 7,943,493.79 | 7,895,012.66 |
| 资产减值损失(新) | -7,873.66 | -1,204,587.77 | 1,246,857.59 | 911,697.76 |
| 信用减值损失(新) | 338,096.79 | -6,831,283.97 | -2,545,129.87 | 510,134.82 |
| 其他收益 | 1,167,337.16 | 7,387,605.23 | 3,433,376.27 | 2,349,598.39 |
| 四、营业利润 | 5,705,370.75 | 79,775,771.77 | 70,853,872.88 | 30,969,258.94 |
| 加:营业外收入 | 7,729,000 | 18,917,675 | 12,238,913.39 | 9,024,543.49 |
| 减:营业外支出 | 45,541.24 | 7,899,611.61 | 5,723,452.46 | 4,430,200.21 |
| 五、利润总额 | 13,388,829.51 | 90,793,835.16 | 77,369,333.81 | 35,563,602.22 |
| 减:所得税费用 | 5,422,064.61 | 34,356,521.53 | 28,898,536.63 | 19,230,101.3 |
| 六、净利润 | 7,966,764.9 | 56,437,313.63 | 48,470,797.18 | 16,333,500.92 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 8,188,319.67 | 59,605,414.73 | 48,470,797.18 | 16,333,500.92 |
| 终止经营净利润 | -221,554.77 | -3,168,101.1 | - | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,342,275.14 | 24,850,904.53 | 22,327,426.51 | 380,868.67 |
| 少数股东损益 | 4,624,489.76 | 31,586,409.1 | 26,143,370.67 | 15,952,632.25 |
| 扣除非经常损益后的净利润 | 1,706,208.27 | 31,755,382.48 | 17,526,985.32 | -5,011,716.56 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.01 | 0.1 | 0.09 | 0 |
| (二)稀释每股收益 | 0.01 | 0.1 | 0.09 | 0 |
| 九、综合收益总额 | 7,966,764.9 | 56,437,313.63 | 48,470,797.18 | 16,333,500.92 |
| 归属于母公司股东的综合收益总额 | 3,342,275.14 | 24,850,904.53 | 22,327,426.51 | 380,868.67 |
| 归属于少数股东的综合收益总额 | 4,624,489.76 | 31,586,409.1 | 26,143,370.67 | 15,952,632.25 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-30 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |